ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,881 | -74.2% | 757,826 | 0.0% | 0.00% | – |
| Q2 2023 | $386,491 | -21.6% | 757,826 | -3.1% | 0.00% | – |
| Q1 2023 | $492,676 | -51.5% | 782,025 | -50.0% | 0.00% | – |
| Q4 2022 | $1,015,224 | -81.4% | 1,564,050 | -50.8% | 0.00% | – |
| Q3 2022 | $5,467,000 | +410.9% | 3,178,423 | +268.3% | 0.00% | – |
| Q2 2022 | $1,070,000 | -68.5% | 863,026 | -83.5% | 0.00% | – |
| Q1 2022 | $3,402,000 | -76.6% | 5,215,353 | -60.8% | 0.00% | -100.0% |
| Q4 2021 | $14,517,000 | -31.7% | 13,318,734 | +14.1% | 0.00% | 0.0% |
| Q3 2021 | $21,250,000 | -25.9% | 11,676,032 | +7.5% | 0.00% | -50.0% |
| Q2 2021 | $28,670,000 | -34.7% | 10,859,732 | -11.0% | 0.00% | -33.3% |
| Q1 2021 | $43,925,000 | +98.9% | 12,201,348 | +39.2% | 0.00% | +200.0% |
| Q4 2020 | $22,087,000 | -7.1% | 8,764,826 | -7.1% | 0.00% | -50.0% |
| Q3 2020 | $23,780,000 | -10.0% | 9,436,633 | +17.1% | 0.00% | 0.0% |
| Q2 2020 | $26,435,000 | +68.6% | 8,059,494 | +26.0% | 0.00% | +100.0% |
| Q1 2020 | $15,676,000 | -44.1% | 6,398,385 | +7.8% | 0.00% | -50.0% |
| Q4 2019 | $28,025,000 | -7.9% | 5,937,591 | -16.4% | 0.00% | 0.0% |
| Q3 2019 | $30,416,000 | -5.8% | 7,106,445 | +28.3% | 0.00% | 0.0% |
| Q2 2019 | $32,285,000 | +55.2% | 5,537,807 | +2.5% | 0.00% | 0.0% |
| Q1 2019 | $20,801,000 | +121.1% | 5,402,958 | +7.4% | 0.00% | +100.0% |
| Q4 2018 | $9,408,000 | -47.4% | 5,030,987 | -9.9% | 0.00% | 0.0% |
| Q3 2018 | $17,873,000 | +18.6% | 5,585,412 | +12.0% | 0.00% | 0.0% |
| Q2 2018 | $15,070,000 | -42.3% | 4,988,998 | -25.1% | 0.00% | -50.0% |
| Q1 2018 | $26,101,000 | +8.3% | 6,657,400 | +14.3% | 0.00% | 0.0% |
| Q4 2017 | $24,105,000 | -11.5% | 5,822,561 | +31.2% | 0.00% | 0.0% |
| Q3 2017 | $27,237,000 | -3.9% | 4,436,599 | -2.6% | 0.00% | -33.3% |
| Q2 2017 | $28,342,000 | +10.7% | 4,556,264 | +12.8% | 0.00% | +50.0% |
| Q1 2017 | $25,607,000 | +19.2% | 4,039,207 | +0.6% | 0.00% | 0.0% |
| Q4 2016 | $21,490,000 | -20.3% | 4,016,343 | -16.1% | 0.00% | -33.3% |
| Q3 2016 | $26,948,000 | +5.5% | 4,785,467 | +2.8% | 0.00% | 0.0% |
| Q2 2016 | $25,546,000 | -19.0% | 4,653,446 | +9.5% | 0.00% | 0.0% |
| Q1 2016 | $31,547,000 | -26.2% | 4,251,134 | -17.4% | 0.00% | -40.0% |
| Q4 2015 | $42,765,000 | +13.4% | 5,146,077 | +22.9% | 0.01% | +25.0% |
| Q3 2015 | $37,727,000 | -29.4% | 4,187,646 | -6.0% | 0.00% | -33.3% |
| Q2 2015 | $53,437,000 | +57.1% | 4,453,027 | +41.0% | 0.01% | +100.0% |
| Q1 2015 | $34,017,000 | +100.6% | 3,158,903 | -5.6% | 0.00% | +50.0% |
| Q4 2014 | $16,958,000 | +98.0% | 3,344,666 | +3.1% | 0.00% | +100.0% |
| Q3 2014 | $8,564,000 | -43.4% | 3,244,772 | -13.5% | 0.00% | -50.0% |
| Q2 2014 | $15,125,000 | -21.5% | 3,753,085 | -10.8% | 0.00% | 0.0% |
| Q1 2014 | $19,273,000 | -19.7% | 4,207,715 | -25.1% | 0.00% | 0.0% |
| Q4 2013 | $23,988,000 | +468.7% | 5,619,492 | +426.2% | 0.00% | +100.0% |
| Q3 2013 | $4,218,000 | +87.8% | 1,067,905 | -0.3% | 0.00% | – |
| Q2 2013 | $2,246,000 | – | 1,070,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |